Bo Ahrén

20PUBLICATIONS
23CO-AUTHORS
Food properties (incl. characteristics and health benefits)Nutrigenomics and personalised nutritionPharmacogenomicsClinical pharmacology and therapeuticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 24, 2025
A Randomized, Placebo-Controlled, Single-Center, Crossover Study to Evaluate the Effects of Pre-Meal Whey Protein Microgel on Post-Prandial Glucometabolic and Amino Acid Response in People with Type 2 Diabetes and Overweight or Obesity.

Ian J Neeland, Luiz H de Gregório, Roberto Zagury

|Nov 11, 2023
Paradigm Shift in the Management of Metabolic Diseases-Next-Generation Incretin Therapy.

Bo Ahrén

|Oct 12, 2023
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China.

Linong Ji, A J Ahmann, B Ahrén

|May 20, 2023
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.

Matthias Tschöp, Ruben Nogueiras, Bo Ahrén

|Dec 20, 2022
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation.

Wathik Alsalim, Ola Lindgren, Bo Ahrén

|May 19, 2022
Glucose-dependent insulinotropic polypeptide secretion after oral macronutrient ingestion: The human literature revisited and a systematic study in model experiments in mice.

Bo Ahrén

Pageof 4

Frequent Collaborators

2 joint publications

Wathik Alsalim

1 joint publications

H Imberg

1 joint publications

M Lind

1 joint publications

Linong Ji